Trial intelligence / Profile preview

Mirabegron for alleviating double J ureteral stent-related symptoms

TCTR20210420005Phase 2Completed

Sponsor
Ramathibodi Hospital
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of mirabegron, sponsored by Ramathibodi Hospital. Started Apr 2021; status: completed.

02

Drugs

mirabegron

Beyond the preview

Go deeper on TCTR20210420005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210420005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call